Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 1997

View Archived Issues

Company Profile: CV Therapeutics

Distribution agreement signed for periodontal tissue monitor kit

New prodrug approach claimed by Merck & Co.

Dopamine synthesis and release inhibitors discovered at AHP

Neurokinin antagonists in the pipeline at Schering-Plough

Anandamide amidase inhibitors reported in patent literature

U.S. patent issued for Sertoli cell technology

New discovery opens the way toward a potential new application for estrogen-like drugs

Lilly research leads to the discovery of new antiobesity compounds

Virus Research Institute: Q3 1997 highlights

GH secretagogues under development at Merck

New muscarinic acetylcholine receptor modulators from Novo Nordisk

Cortex/U. of California researchers disclose ampakine-like compounds

Therapeutics discovery collaboration formed by Ontogeny and ArQule

Forbes files IND to begin phase II trials of Cardiorex in primary hypercholesterolemia

U.K. launch for inhaled nicotine replacement therapy

New launches for Abelcet; The Liposome Co./Wyeth-Ayerst partnership broadened

Chiron's Proleukin recommended for approval for new indication

NeoPharm pursues FDA approval of Neomark following negative advisory committee decision

Biorex and Abbott sign definitive agreement for bimoclomol

Results from animal studies with OPC-14523 presented

Sustiva trials now open to more AIDS patients

Mechanism of antiparkinsonian activity of KW-6002 explored in mice

Efficacy of PR-000608 in mouse model of Parkinson's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...